TABLE 4.
Genes chosen for confirmation by qRT-PCR
Genea | GenBank accession no. | Description | Fold changeb |
---|---|---|---|
BLB1 | NM_001044694 | MHC class II antigen B-F minor heavy chain | 203–263* |
SRFBP1 | XM_424408 | Serum response factor binding protein 1 | 24–25* |
TNFRSF1B | NM_204439 | Tumor necrosis factor receptor superfamily, member 1B | 8–9* |
XRCC3 | NM_001006489 | X-ray repair complementing defective repair in Chinese hamster cells 3 | 14–20* |
AICDA | XM_416483 | Activation-induced cytidine deaminase | 8–57† |
B6.3 | X92865 | B cell marker chB6 (Bu-1) | 6–42† |
BLVRA | XM_418872 | Biliverdin reductase A | 8–42† |
CARD9 | XM_425329 | Caspase recruitment domain family, member 9 | 3–16† |
MYBL1 | NM_205232 | Myeloblastosis oncogene-like 1 | 7–37† |
TLR2B | AB046533 | Toll-like receptor 2, type 2 | 4–5† |
CCL19 | XM_424980 | CCL19 homeostatic chemokine | 84–99‡ |
CCLi3 | NM_204720 | CCLi3 MIP family chemokine | 76–100‡ |
CCLi4 | NM_001045832.1 | CCL5 MIP family chemokine (RANTES) | 209–318‡ |
CXCLi2 | NM_205498 | CXCLi2 (IL-8 homologue) | 50–65‡ |
IFNA | EU334503 | IFN-α | 470–1,359‡ |
IFNB | NM_001024836 | IFN-β | 51–85‡ |
IFNG | NM_205149 | IFN-γ | 32–72‡ |
IL13RA2 | NM_001048078 | IL-13 receptor-α2 | 53–111‡ |
IL-6 | NM_204628 | IL-6 | 52–198‡ |
MMP9 | NM_204667 | Matrix metalloprotein 9 | 1,099–1,782‡ |
Mx1 | NM_204609 | Myxovirus resistance gene 1 | 60–69‡ |
Genes indicated in boldface are potential candidate resistance genes.
*, Inherently higher expression in the resistant line; †, higher expression in response to infection in the resistant than in the susceptible line; ‡, upregulated in response to infection in the susceptible line.